Metis Global Partners LLC Sells 721 Shares of Synopsys, Inc. $SNPS

Metis Global Partners LLC lowered its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 7.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,565 shares of the semiconductor company’s stock after selling 721 shares during the period. Metis Global Partners LLC’s holdings in Synopsys were worth $4,391,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Independence Bank of Kentucky lifted its stake in shares of Synopsys by 120.0% during the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 30 shares during the last quarter. Saudi Central Bank bought a new position in Synopsys in the first quarter worth about $26,000. Princeton Global Asset Management LLC boosted its holdings in shares of Synopsys by 481.8% in the 2nd quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock valued at $33,000 after buying an additional 53 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd grew its position in shares of Synopsys by 441.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock worth $28,000 after buying an additional 53 shares during the last quarter. Finally, AlphaQuest LLC raised its stake in shares of Synopsys by 423.1% during the 2nd quarter. AlphaQuest LLC now owns 68 shares of the semiconductor company’s stock worth $35,000 after acquiring an additional 55 shares in the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Synopsys

In other Synopsys news, CAO Sudhindra Kankanwadi sold 9,873 shares of the company’s stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $500.90, for a total value of $4,945,385.70. Following the sale, the chief accounting officer directly owned 20,520 shares of the company’s stock, valued at approximately $10,278,468. This represents a 32.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Sassine Ghazi sold 11,366 shares of Synopsys stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total value of $6,694,687.66. Following the transaction, the chief executive officer owned 71,615 shares of the company’s stock, valued at $42,181,951.15. The trade was a 13.70% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 30,894 shares of company stock valued at $16,760,783 in the last three months. Company insiders own 0.62% of the company’s stock.

Wall Street Analyst Weigh In

SNPS has been the topic of several analyst reports. Wells Fargo & Company cut their price target on shares of Synopsys from $630.00 to $550.00 and set an “equal weight” rating on the stock in a report on Wednesday, September 10th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a research report on Wednesday, October 8th. Zacks Research downgraded Synopsys from a “hold” rating to a “strong sell” rating in a report on Friday, September 12th. Citigroup downgraded shares of Synopsys from a “neutral” rating to an “underperform” rating in a report on Wednesday, September 10th. Finally, Piper Sandler decreased their price objective on shares of Synopsys from $660.00 to $630.00 and set an “overweight” rating for the company in a research report on Wednesday, September 10th. Ten equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat, Synopsys presently has an average rating of “Hold” and an average target price of $569.67.

Synopsys Trading Down 0.7%

Synopsys stock opened at $393.43 on Friday. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The company has a market capitalization of $73.08 billion, a price-to-earnings ratio of 30.88, a price-to-earnings-growth ratio of 5.02 and a beta of 1.10. The stock has a 50-day moving average price of $475.14 and a 200 day moving average price of $514.87.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The business had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same quarter last year, the company posted $3.43 EPS. Synopsys’s quarterly revenue was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Sell-side analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.